Phase i trialist
Lancet Oncol
.
2012 Mar;13(3):236.
doi: 10.1016/s1470-2045(12)70098-0.
Author
Jacob Scott
1
Affiliation
1
jacob.g.scott@gmail.com
PMID:
22489289
DOI:
10.1016/s1470-2045(12)70098-0
No abstract available
MeSH terms
Biomedical Research*
Humans
Medical Oncology*
Models, Biological*